US Patent 11028182 Antigen-binding constructs targeting HER2
Patent 11028182 was granted and assigned to Zymeworks Inc. on June, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11028182 Antigen-binding constructs targeting HER2
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
